Semler Scientific (NASDAQ:SMLR) Shares Up 7.1% – Here’s Why

Semler Scientific, Inc. (NASDAQ:SMLR)’s stock price traded up 7.1% on Monday . The stock traded as high as $61.50 and last traded at $61.08. 445,802 shares were traded during trading, an increase of 71% from the average session volume of 261,239 shares. The stock had previously closed at $57.02.

Semler Scientific Stock Performance

The business’s 50-day simple moving average is $35.84 and its 200-day simple moving average is $32.09. The company has a market capitalization of $503.23 million, a price-to-earnings ratio of 27.81 and a beta of 0.92.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The business had revenue of $13.51 million for the quarter.

Hedge Funds Weigh In On Semler Scientific

Institutional investors and hedge funds have recently modified their holdings of the business. Cerity Partners LLC raised its position in Semler Scientific by 91.5% in the 3rd quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock valued at $31,689,000 after buying an additional 642,982 shares during the last quarter. Shariaportfolio Inc. acquired a new stake in shares of Semler Scientific in the third quarter valued at approximately $3,618,000. AQR Capital Management LLC raised its holdings in shares of Semler Scientific by 150.1% in the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock valued at $4,833,000 after purchasing an additional 84,314 shares during the last quarter. Crawford Fund Management LLC bought a new stake in Semler Scientific during the 3rd quarter worth about $883,000. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Semler Scientific by 18.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after buying an additional 19,552 shares during the last quarter. 49.37% of the stock is currently owned by institutional investors and hedge funds.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.